Ironwood Pharma (IRWD) Reports Q1 Lost Per Share of 24c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Leerink Lowers PT after Ironwood Pharmaceuticals (IRWD) 1Q Results
May 6, 2015 11:00 AM EDTLeerink Partners reiterates a Market Perform rating on Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and lowers its price target to $16 (from $17) after weak 1Q sales. The Linzess profit share fell short of street expectations due to challenging sales, and seasonality, the analyst notes
Leerink analyst... More
